SLC18A2 gene
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| SLC18A2 | risk_factor_for | alcohol dependence | — | 1 |
| SLC18A2 | biomarker_for | dopaminergic neurons | — | 1 |
Mentioned in (6)
Papers in which this entity is mentioned.
- Induced neuronal reprogramming. (2014)
- Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. (2011)
- Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. (2009)
- Causes and consequences of methamphetamine and MDMA toxicity. (2006)
- Structural abnormalities in the brains of human subjects who use methamphetamine. (2004)
- Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. (1998)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| slc18a2 | gene | 4 | 7 |
| vmat2 | gene | 2 | 3 |
| vesicular monoamine transporter 2 | gene | 1 | 1 |
| synaptic vesicular amine transporter | gene | — | — |